GSK’s kidney disease anaemia drug approved in Japan, taking on Astellas’ rival

GlaxoSmithKline’s drug for anaemia caused by chronic kidney disease daprodustat has been approved in Japan, taking on a recently approved rival from Astellas.  Marketed